SCHEMBL20101041

SCHEMBL20101041

Cc1cc(C)nc(N/N=C(\c2ccccc2)c2ccccn2)n1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.74
LMNA P02545 7/20 0.74
HTT P42858 6/20 0.74
ALDH1A1 P00352 5/20 0.74
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
GAA P10253 3/20 0.56
HPGD P15428 3/20 0.56
ALOX12 P18054 1/20 0.56
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
HIF1A Q16665 1/20 0.54
HSP90AA1 P07900 1/20 0.54
AGTR1 P30556 4/20 0.53
KDM4E B2RXH2 2/20 0.53
KDM6B O15054 1/20 0.53
TET3 O43151 1/20 0.53
KDM4A O75164 1/20 0.53
KDM4B O94953 1/20 0.53
KDM5A P29375 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20101040 0.82 PAX8 (0.57) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL6756762 0.82 PAX8 (0.57) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL6756763 0.82 PAX8 (0.57) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL20101032 0.80 KDM4E (0.58) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL18292348 0.78 KMT2A (0.81) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL20101033 0.77 KDM4E (0.58) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL4926318 0.77 KDM4E (0.72) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL20101080 0.77 KDM4E (0.72) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL30779129 0.76 AGTR1 (0.65) SMN1; SMN2LMNAHTTALDH1A1MEN1
SCHEMBL30779140 0.76 AGTR1 (0.65) SMN1; SMN2LMNAHTTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081612-A1 COMPOUNDS AND METHODS FOR TREATING CANCER ACTAVALON, INC. (US) 2018-05-03 WO disclosed